Swiss National Bank’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.16M | Hold |
61,100
| – | – | ﹤0.01% | 1816 |
|
|
2025
Q4 | $2.48M | Buy |
61,100
+1,100
| +2% | +$47.9K | ﹤0.01% | 1765 |
|
|
2025
Q3 | $2.82M | Buy |
60,000
+900
| +2% | +$46.7K | ﹤0.01% | 1672 |
|
|
2025
Q2 | $3.08M | Sell |
59,100
-800
| -1% | -$43.9K | ﹤0.01% | 1556 |
|
|
2025
Q1 | $3.62M | Sell |
59,900
-700
| -1% | -$45.1K | ﹤0.01% | 1437 |
|
|
2024
Q4 | $4.15M | Buy |
60,600
+500
| +0.8% | +$34.8K | ﹤0.01% | 1445 |
|
|
2024
Q3 | $4.32M | Sell |
60,100
-500
| -0.8% | -$35.3K | ﹤0.01% | 1412 |
|
|
2024
Q2 | $4.2M | Hold |
60,600
| – | – | ﹤0.01% | 1379 |
|
|
2024
Q1 | $4.85M | Hold |
60,600
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q4 | $6.64M | Sell |
60,600
-6,700
| -10% | -$693K | ﹤0.01% | 1106 |
|
|
2023
Q3 | $6.79M | Buy |
67,300
+700
| +1% | +$80.4K | 0.01% | 1100 |
|
|
2023
Q2 | $9.05M | Buy |
66,600
+800
| +1% | +$97.7K | 0.01% | 964 |
|
|
2023
Q1 | $6.83M | Sell |
65,800
-7,700
| -10% | -$745K | ﹤0.01% | 1077 |
|
|
2022
Q4 | $6.52M | Buy |
73,500
+3,500
| +5% | +$290K | ﹤0.01% | 1156 |
|
|
2022
Q3 | $5.61M | Buy |
70,000
+800
| +1% | +$75.5K | ﹤0.01% | 1207 |
|
|
2022
Q2 | $6.63M | Hold |
69,200
| – | – | ﹤0.01% | 1154 |
|
|
2022
Q1 | $10.3M | Buy |
69,200
+5,000
| +8% | +$698K | 0.01% | 1012 |
|
|
2021
Q4 | $9.1M | Sell |
64,200
-100
| -0.2% | -$14.2K | 0.01% | 1062 |
|
|
2021
Q3 | $8.41M | Buy |
64,300
+500
| +0.8% | +$65.4K | 0.01% | 1092 |
|
|
2021
Q2 | $8.77M | Sell |
63,800
-1,600
| -2% | -$219K | 0.01% | 1093 |
|
|
2021
Q1 | $8.54M | Buy |
65,400
+700
| +1% | +$84.2K | 0.01% | 1092 |
|
|
2020
Q4 | $7.25M | Hold |
64,700
| – | – | 0.01% | 1127 |
|
|
2020
Q3 | $5.09M | Buy |
64,700
+1,100
| +2% | +$89.7K | ﹤0.01% | 1168 |
|
|
2020
Q2 | $4.58M | Buy |
63,600
+8,600
| +16% | +$598K | ﹤0.01% | 1198 |
|
|
2020
Q1 | $3.15M | Buy |
55,000
+800
| +1% | +$73.8K | ﹤0.01% | 1180 |
|
|
2019
Q4 | $6.06M | Buy |
54,200
+1,100
| +2% | +$117K | 0.01% | 1030 |
|
|
2019
Q3 | $5.11M | Buy |
53,100
+800
| +2% | +$75.1K | 0.01% | 1087 |
|
|
2019
Q2 | $4.47M | Buy |
52,300
+6,100
| +13% | +$501K | ﹤0.01% | 1195 |
|
|
2019
Q1 | $3.84M | Buy |
46,200
+1,500
| +3% | +$109K | ﹤0.01% | 1249 |
|
|
2018
Q4 | $2.87M | Buy |
44,700
+900
| +2% | +$61.6K | ﹤0.01% | 1330 |
|
|
2018
Q3 | $3.47M | Hold |
43,800
| – | – | ﹤0.01% | 1361 |
|
|
2018
Q2 | $3.21M | Hold |
43,800
| – | – | ﹤0.01% | 1396 |
|
|
2018
Q1 | $2.77M | Buy |
43,800
+2,100
| +5% | +$125K | ﹤0.01% | 1428 |
|
|
2017
Q4 | $2.13M | Hold |
41,700
| – | – | ﹤0.01% | 1613 |
|
|
2017
Q3 | $2.19M | Hold |
41,700
| – | – | ﹤0.01% | 1560 |
|
|
2017
Q2 | $2.12M | Buy |
41,700
+2,400
| +6% | +$119K | ﹤0.01% | 1560 |
|
|
2017
Q1 | $1.75M | Hold |
39,300
| – | – | ﹤0.01% | 1649 |
|
|
2016
Q4 | $1.74M | Hold |
39,300
| – | – | ﹤0.01% | 1653 |
|
|
2016
Q3 | $1.57M | Sell |
39,300
-2,600
| -6% | -$110K | ﹤0.01% | 1667 |
|
|
2016
Q2 | $2M | Sell |
41,900
-1,100
| -3% | -$46.6K | ﹤0.01% | 1506 |
|
|
2016
Q1 | $1.75M | Buy |
43,000
+7,600
| +21% | +$298K | ﹤0.01% | 1527 |
|
|
2015
Q4 | $1.56M | Hold |
35,400
| – | – | ﹤0.01% | 1509 |
|
|
2015
Q3 | $1.69M | Buy |
35,400
+4,200
| +13% | +$231K | ﹤0.01% | 1418 |
|
|
2015
Q2 | $1.82M | Sell |
31,200
-1,800
| -5% | -$97.1K | ﹤0.01% | 1373 |
|
|
2015
Q1 | $1.67M | Buy |
33,000
+500
| +2% | +$24.5K | ﹤0.01% | 1414 |
|
|
2014
Q4 | $1.46M | Buy |
32,500
+700
| +2% | +$29.3K | 0.01% | 1496 |
|
|
2014
Q3 | $1.17M | Sell |
31,800
-900
| -3% | -$35.7K | ﹤0.01% | 1571 |
|
|
2014
Q2 | $1.44M | Hold |
32,700
| – | – | 0.01% | 1493 |
|
|
2014
Q1 | $1.42M | Buy |
32,700
+6,800
| +26% | +$303K | 0.01% | 1465 |
|
|
2013
Q4 | $1.1M | Hold |
25,900
| – | – | ﹤0.01% | 1440 |
|
|
2013
Q3 | $880K | Sell |
25,900
-1,500
| -5% | -$48.9K | ﹤0.01% | 1545 |
|
|
2013
Q2 | $856K | Buy |
+27,400
| New | +$889K | ﹤0.01% | 1532 |
|
Other funds holding CNMD
VPM
VCM
CB
Swiss National Bank's CNMD Position: Q1 2026 in Review
Swiss National Bank held its CONMED (CNMD) position steady in Q1 2026 at 61,100 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.
Swiss National Bank first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.3M in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Swiss National Bank held 61,100 shares of CONMED worth $2.16M as of Q1 2026.
- Swiss National Bank left its CONMED share count unchanged in Q1 2026.
- CONMED made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1816 holding.
- Swiss National Bank first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's CONMED position peaked at $10.3M in Q1 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.